[PRLD] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[PRLD] Prelude Therapeutics Incorporated
Announcement Date
15-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -8.06%
YoY- -57.60%
Quarter Report
PRLD's Result
PRLD's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
Revenue 3,424 0 0 0 0 -
PBT -33,075 -28,641 -32,842 -19,250 -10,039 34.69%
Tax 1,676 -7,654 -168 0 0 -
NP -33,075 -20,987 -32,842 -19,250 -10,039 34.69%
Tax Rate - - - - - -
Total Cost 36,499 20,987 32,842 19,250 10,039 38.05%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
NP Margin -965.98 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
EPS -0.48 -0.44 -0.71 -0.51 -0.31 11.54%
EPS Diluted -0.48 -0.44 -0.71 -0.51 -0.31 11.54%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.